Form 4 for ZLAB Zai Lab Ltd
Accepted 2021-09-08 00:00:00 ET · period of report 2021-09-07 · accession 0001567619-21-016870 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-09-08 | 2021-09-07 | ZLAB | Reinhart Harald | Chief Medical Off | S - Sale+OE | $150.93 | -10.0K | 9,900 | -50% | -$1.51M |
| D | 2021-09-08 | 2021-09-07 | ZLAB | Reinhart Harald | Chief Medical Off | M - OptEx | $3.00 | +10.0K | 10.0K | New | +$30.0K |
| D | 2021-09-08 | 2021-09-07 | ZLAB | Reinhart Harald | Chief Medical Off | M - OptEx | $0.00 | -10.0K | 23.3K | -30% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2021-09-07 | S | D | 200 | $146.98 | 9,700 | D | — | — | (F2) Reflects a weighted average sale price of $146.98 per share, at prices ranging from $146.66 to $147.30 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. |
| 2 | Common | Ordinary Shares | 2021-09-07 | M | A | 10,000 | $3.00 | 10,000 | D | — | — | |
| 3 | Common | Ordinary Shares | 2021-09-07 | S | D | 300 | $148.69 | 9,400 | D | — | — | (F3) Reflects a weighted average sale price of $148.69 per share, at prices ranging from $148.23 to $148.92 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. |
| 4 | Common | Ordinary Shares | 2021-09-07 | S | D | 2,000 | $150.41 | 7,400 | D | — | — | (F4) Reflects a weighted average sale price of $150.41 per share, at prices ranging from $149.80 to $150.78 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. |
| 5 | Common | Ordinary Shares | 2021-09-07 | S | D | 6,600 | $151.28 | 800 | D | — | — | (F5) Reflects a weighted average sale price of $151.28 per share, at prices ranging from $150.84 to $151.82 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. |
| 6 | Common | Ordinary Shares | 2021-09-07 | S | D | 800 | $152.11 | 0 | D | — | — | (F6) Reflects a weighted average sale price of $152.11 per share, at prices ranging from $151.85 to $152.50 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. |
| 7 | Common | Ordinary Shares | 2021-09-07 | S | D | 100 | $143.00 | 9,900 | D | — | — | |
| 8 | Derivative | Stock Options (Right to Buy) | 2021-09-07 | M | D | 10,000 | $0.00 | 23,334 | D | $3.00 · — to 2027-05-12 | 10,000 Ordinary Shares | (F7) The options vest in equal annual installments over four years beginning on 5/12/2018, the first anniversary of the date of grant. |